Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BOM:524548's ROE % is ranked better than 61.74% of 622
companies
in the Healthcare Providers & Services industry
Industry Median: 5.895
vs BOM:524548: 9.48
Sharma East India Hospitals & Medical Research (BOM:524548) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Sharma East India Hospitals & Medical Research ROE % Related Terms
Sharma East India Hospitals & Medical Research ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sharma East India Hospitals & Medical Research ROE % Chart
Sharma East India Hospitals & Medical Research Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sharma East India Hospitals & Medical Research ROE % vs Healthcare Providers & Services Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Sharma East India Hospitals & Medical Research (BOM:524548) has a ROE % of 12.51% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Sharma East India Hospitals & Medical Research and its competitors. This is 86% above median its historical median of 6.72. Over the past decade, Sharma East India Hospitals & Medical Research's ROE % has ranged from 1.13 to 10.50. According to the industry distribution chart, Sharma East India Hospitals & Medical Research ranks #238 out of 622 companies in the Healthcare Providers & Services industry, placing it in the top 38.3%.
Is Sharma East India Hospitals & Medical Research's ROE % too high?
Sharma East India Hospitals & Medical Research's current ROE % of 12.51% is 86% above median its 10-year median of 6.72. Over the past 10 years, this metric has ranged from a low of 1.13 to a high of 10.50. The Healthcare Providers & Services industry median ROE % is 5.90. Sharma East India Hospitals & Medical Research's value of 12.51% is 112.2% above this industry median. Based on the distribution chart, Sharma East India Hospitals & Medical Research ranks #238 out of 622 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sharma East India Hospitals & Medical Research has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sharma East India Hospitals & Medical Research's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sharma East India Hospitals & Medical Research ranks #238 out of 622 companies for ROE %. This puts Sharma East India Hospitals & Medical Research in the upper half of its industry. The industry median ROE % is 5.90. Sharma East India Hospitals & Medical Research's value of 12.51% is 112.2% above this benchmark. Historically, Sharma East India Hospitals & Medical Research's own ROE % has ranged from 1.13 to 10.50 over the past decade. While the company's 10-year median is 6.72 vs. the industry median of 5.90, Sharma East India Hospitals & Medical Research has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.90, based on 622 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sharma East India Hospitals & Medical Research's current ROE % of 12.51% is 112.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Sharma East India Hospitals & Medical Research and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sharma East India Hospitals & Medical Research's current ROE % is 12.51%, which is 86% above median its own 10-year median of 6.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sharma East India Hospitals & Medical Research stock overvalued right now?
Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research (BOM:524548) is currently considered Fairly Valued. The stock's GF Value™ is ₹101.98, compared to a current price of ₹99.78 — trading 2.2% below its estimated fair value. The current ROE % is 12.51%, which is 86% above median its 10-year median of 6.72 and 112.2% above the Healthcare Providers & Services industry median of 5.90. Sharma East India Hospitals & Medical Research's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Sharma East India Hospitals & Medical Research (BOM:524548), the current ROE % is 12.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sharma East India Hospitals & Medical Research (BOM:524548) Overvalued in 2026?
Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research stock appears to be undervalued.
The current stock price of ₹99.78 is trading 2.2% below its estimated GF Value™ of ₹101.98.
GuruFocus considers Sharma East India Hospitals & Medical Research to be Fairly Valued.
Key valuation signals for BOM:524548:
ROE %: 12.51% (86% above median its 10-year median of 6.72)
GF Value™: ₹101.98 vs. price of ₹99.78 (2.2% below fair value)
Industry Position: 112.2% above the Healthcare Providers & Services median (#238 of 622)
No single metric tells the full story. See the BOM:524548 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sharma East India Hospitals & Medical Research Business Description
Sharma East India Hospitals & Medical Research Ltd is engaged in service activities related to the medical and healthcare services and real estate services. It provides healthcare services through the multi-specialty hospital in the name of Jaipur Hospital in Rajasthan. It provides services like joint replacement surgery, arthroscopy, cardiothoracic and vascular surgery, interventional cardiology, such as angiography and angioplasty, neurosurgery, and others.
77GF Score
Get the complete analysis for BOM:524548
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524548 has been successfully added to your 
